Public procurement notice: Voluntary Ex Ante Transparency Notice
Published: 2021-11-22
Buyer: SYKEHUSINNKJØP HF
Country: NO
Contract type: Supplies
Procedure: Contract award without prior publication
CPV classification: 33600000: Pharmaceutical products
Estimated value: 1000000 NOK
Award criteria: Lowest price

Technical requirements: Sykehusinnkjøp HF, Divisjon legemidler [the Norwegian Hospital Procurement Trust, the Pharmaceutical Division] is collecting offers for pharmaceuticals used by the health trusts. The Pharmaceutical Division (Norwegian abbreviation: LIS) has previously published and held an open tender contest for non-parenteral special pharmaceutical preparations ('LIS 2201b non-parenteral special pharmaceutical preparations').
The contest was for the delivery of active ingredients in accordance with the tender documentation, annex 3 price sheet. Following the implementation of the contest, offers have been made for Buccolam mouthwash ATC code N05CD08). We received no other tenders for the relevant ATC code included in the tender contest. Based on this information, the Pharmaceutical Division intends to intends to enter into contracts between the regional health authorities (the contracting authorities) and Laboratorios Lesvi, S.L. (The tenderer) in supplementary contract to LIS 2201b, i.e. The scope and duration of the contract will follow the named procurement (hereunder access to extension and cancellation), without publication of a new contest for this active ingredient.
Sykehusinnkjøp HF, Divisjon legemidler [the Norwegian Hospital Procurement Trust, the Pharmaceutical Division] is collecting offers for pharmaceuticals used by the health trusts. The Pharmaceutical Division (Norwegian abbreviation: LIS) has previously published and held an open tender contest for non-parenteral special pharmaceutical preparations ('LIS 2201b non-parenteral special pharmaceutical preparations').
The contest was for the delivery of active ingredients in accordance with the tender documentation, annex 3 price sheet. Following the implementation of the contest, offers have been made for Buccolam mouthwash ATC code N05CD08). We received no other tenders for the relevant ATC code included in the tender contest. Based on this information, the Pharmaceutical Division intends to intends to enter into contracts between the regional health authorities (the contracting authorities) and Laboratorios Lesvi, S.L. (The tenderer) in supplementary contract to LIS 2201b, i.e. The scope and duration of the contract will follow the named procurement (hereunder access to extension and cancellation), without publication of a new contest for this active ingredient.
The health companies that are under the regional health trusts have an option to enter into the contracts. The same applies for non-profit institutions/hospitals with an operational contract with each health region. The Pharmaceutical Division has examined the market situation and is of the opinion that it is not possible to hold a new contest or that a supplier other than Laboratorios Lesvi, S.L. can deliver the product in the pending contract period, and that the situation that has arisen is not due to the contracting authority or that the contracting authority could foresee. The Pharmaceutical Division therefore means there is LIS therefore believes that there is a legal basis to carry out the procurement without a contest. Refer to the Public Procurement Regulation §13-4, letter b, no. 3. LIS requests that those who have objections to the intended contract award submit feedback before the waiting period expires on 25.11.2021. If no objections are received, contracts will be signed after the waiting period has expired
Sykehusinnkjøp HF, Divisjon legemidler [the Norwegian Hospital Procurement Trust, the Pharmaceutical Division] is collecting offers for pharmaceuticals used by the health trusts. The Pharmaceutical Division (Norwegian abbreviation: LIS) has previously published and held an open tender contest for non-parenteral special pharmaceutical preparations ('LIS 2201b non-parenteral special pharmaceutical preparations').
The contest was for the delivery of active ingredients in accordance with the tender documentation, annex 3 price sheet. Following the implementation of the contest, offers have been made for Buccolam mouthwash ATC code N05CD08). We received no other tenders for the relevant ATC code included in the tender contest. Based on this information, the Pharmaceutical Division intends to intends to enter into contracts between the regional health authorities (the contracting authorities) and Laboratorios Lesvi, S.L. (The tenderer) in supplementary contract to LIS 2201b, i.e. The scope and duration of the contract will follow the named procurement (hereunder access to extension and cancellation), without publication of a new contest for this active ingredient.
The health companies that are under the regional health trusts have an option to enter into the contracts. The same applies for non-profit institutions/hospitals with an operational contract with each health region. The Pharmaceutical Division has examined the market situation and is of the opinion that it is not possible to hold a new contest or that a supplier other than Laboratorios Lesvi, S.L. can deliver the product in the pending contract period, and that the situation that has arisen is not due to the contracting authority or that the contracting authority could foresee. The Pharmaceutical Division therefore means there is LIS therefore believes that there is a legal basis to carry out the procurement without a contest. Refer to the Public Procurement Regulation §13-4, letter b, no. 3. LIS requests that those who have objections to the intended contract award submit feedback before the waiting period expires on 25.11.2021. If no objections are received, contracts will be signed after the waiting period has expired


Winner: Laboratorios Lesvi, S.L.
Award value: 1000000